{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:49:13Z","timestamp":1792619353299,"version":"4.5.0"},"reference-count":521,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jtos.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:19:09Z","timestamp":1742948349000},"page":"140-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Bringing ophthalmology into the scientific world: Novel nanoparticle-based strategies for ocular drug delivery"],"prefix":"10.1016","volume":"37","author":[{"given":"Milad","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Aghamollaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Vaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-2297","authenticated-orcid":false,"given":"Hesam","family":"Kamyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeshivadasan","family":"Chelliapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Jamalpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambrano-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2025.03.004_bib1","series-title":"World report on vision","year":"2019"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib2","doi-asserted-by":"crossref","DOI":"10.5500\/wjt.v14.i2.95009","article-title":"Whole-eye transplantation: current challenges and future perspectives","volume":"14","author":"Scarabosio","year":"2024","journal-title":"World J Transplant"},{"key":"10.1016\/j.jtos.2025.03.004_bib3","article-title":"Research progress in in-situ gelling ophthalmic drug delivery system","volume":"14","author":"Wu","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib4","doi-asserted-by":"crossref","unstructured":"J. Barar, A. Aghanejad, M. Fathi, Y. Omidi, Advanced drug delivery and targeting technologies for the ocular diseases, Bioimpacts 6(1) 49-67....","DOI":"10.15171\/bi.2016.07"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","article-title":"Nanotechnology-based ocular drug delivery systems: recent advances and future prospects","volume":"21","author":"Li","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","article-title":"Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery","volume":"6","author":"Gupta","year":"2010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114867","article-title":"Non-aqueous formulations in topical ocular drug delivery \u2013 a paradigm shift?","volume":"198","author":"Agarwal","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering9010041","article-title":"Targeting ocular drug delivery: an examination of local anatomy and current approaches","author":"Dosmar","year":"2022","journal-title":"Bioengineering"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/acs.molpharmaceut.1c00650","article-title":"Ophthalmic nanoemulsions: from composition to technological processes and quality control","volume":"18","author":"Gawin-Miko\u0142ajewicz","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.22159\/ijap.2020v12i5.38762","article-title":"Ocular drug delivery system: challenges and approaches","volume":"12","author":"Raj","year":"2020","journal-title":"Int J Appl Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/gels10090589","article-title":"Exploring hydrogel nanoparticle systems for enhanced ocular drug delivery","author":"Arabpour","year":"2024","journal-title":"Gels"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jddst.2016.06.002","article-title":"Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections","volume":"35","author":"Fetih","year":"2016","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib17","article-title":"Nonionic surfactant vesicles (niosomes) for ocular drug delivery: development, evaluation and toxicological profiling","volume":"60","author":"Alyami","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/03639041003610799","article-title":"Preparation and characterization of puerarin\u2013dendrimer complexes as an ocular drug delivery system","volume":"36","author":"Yao","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/jps.24588","article-title":"In vitro\/in vivo evaluation of dexamethasone\u2014PAMAM dendrimer complexes for retinal drug delivery","volume":"104","author":"Yavuz","year":"2015","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2016.03.061","article-title":"The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system","volume":"143","author":"Chen","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies","volume":"17","author":"Li","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jtos.2025.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113560","article-title":"mPEG-CS-modified flexible liposomes-reinforced thermosensitive sol-gel reversible hydrogels for ocular delivery of multiple drugs with enhanced synergism","volume":"231","author":"Peng","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2023.07.052","article-title":"Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment","volume":"361","author":"Ilochonwu","year":"2023","journal-title":"J Contr Release"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ph14111201","article-title":"Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems","volume":"14","author":"Gupta","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"27","key":"10.1016\/j.jtos.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1021\/acsami.0c07517","article-title":"MOF-based polymeric nanocomposite films as potential materials for drug delivery devices in ocular therapeutics","volume":"12","author":"Gandara-Loe","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/pharmaceutics13020192","article-title":"Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (ODDS) for cyclosporine-A","volume":"13","author":"Terreni","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib27","article-title":"Augmented efficiency of azithromycin for MRSA ocular infections management: limonene-based nanostructured lipid carriers in-situ approach","volume":"87","author":"Abla","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijbiomac.2022.12.238","article-title":"Chondroitin sulfate and L-Cysteine conjugate modified cationic nanostructured lipid carriers: pre-corneal retention, permeability, and related studies for dry eye treatment","volume":"228","author":"Zhu","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jtos.2025.03.004_bib29","article-title":"Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (\u00b1)-MRJF22: a potential strategy in the treatment of uveal melanoma","volume":"87","author":"Cimino","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"25","key":"10.1016\/j.jtos.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2217\/nnm-2023-0141","article-title":"Bimatoprost-loaded lipidic nanoformulation development using quality by design: liposomes versus solid lipid nanoparticles in intraocular pressure reduction","volume":"18","author":"Verma","year":"2023","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib31","doi-asserted-by":"crossref","DOI":"10.1515\/ntrev-2022-0517","article-title":"Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers' development","volume":"12","author":"Mohammed","year":"2023","journal-title":"Nanotechnol Rev"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/02652048.2017.1321048","article-title":"Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation","volume":"34","author":"Morsi","year":"2017","journal-title":"J Microencapsul"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2016.04.021","article-title":"Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery","volume":"506","author":"Morsi","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S329831","article-title":"Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective","volume":"16","author":"Zhang","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2025.03.004_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00079","article-title":"Nanoscale drug delivery systems: from medicine to agriculture","volume":"8","author":"Vega-V\u00e1squez","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jtos.2025.03.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108169","article-title":"Cerium oxide nanoparticles reduce the accumulation of autofluorescent deposits in light-induced retinal degeneration: insights for age-related macular degeneration","volume":"199","author":"Tisi","year":"2020","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202300062","article-title":"Mesoporous cerium oxide nanoparticles with high scavenging properties of reactive oxygen species for treating age\u2010related macular degeneration","volume":"3","author":"Choi","year":"2023","journal-title":"Adv NanoBiomed Res"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1021\/acsnano.2c05447","article-title":"Repeated topical administration of 3 nm cerium oxide nanoparticles reverts disease atrophic phenotype and arrests neovascular degeneration in AMD mouse models","volume":"17","author":"Badia","year":"2023","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.jtos.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1088\/0031-9155\/57\/20\/6371","article-title":"Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration","volume":"57","author":"Ngwa","year":"2012","journal-title":"Phys Med Biol"},{"issue":"24","key":"10.1016\/j.jtos.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1088\/0031-9155\/60\/24\/9203","article-title":"Kilovoltage radiosurgery with gold nanoparticles for neovascular age-related macular degeneration (AMD): a Monte Carlo evaluation","volume":"60","author":"Brivio","year":"2015","journal-title":"Phys Med Biol"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1166\/jbn.2024.3847","article-title":"Phacoemulsification plus intraocular lens implantation with gold nanoparticles for complicated cataract secondary to uveitis: efficacy analysis","volume":"20","author":"Kuang","year":"2024","journal-title":"J Biomed Nanotechnol"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1049\/iet-nbt.2017.0003","article-title":"Efficacy of biogenic silver nanoparticles against clinical isolates of fungi causing mycotic keratitis in humans","volume":"11","author":"Lachmapure","year":"2017","journal-title":"IET Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/jop.2012.0155","article-title":"In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi","volume":"29","author":"Xu","year":"2013","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-023-01974-4","article-title":"Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy","volume":"21","author":"Wei","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib46","article-title":"Advancing ocular medication delivery with nano-engineered solutions: a comprehensive review of innovations, obstacles, and clinical impact","volume":"16","author":"Rajan","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1872211314666200127101149","article-title":"Nanoformulations for ocular delivery of drugs - a patent perspective, recent pat drug","volume":"13","author":"Dogra","year":"2019","journal-title":"Deliv Formul"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.327","article-title":"Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models","volume":"4","author":"Xuan","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.jtos.2025.03.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2024.100105","article-title":"Biological uses of nanomaterials within the safe handling and toxic effects: (Brain as a model)","volume":"12","author":"Hamdi","year":"2024","journal-title":"Adv Redox Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep40685","article-title":"Mitochondrial and chromosomal damage induced by oxidative stress in Zn(2+) ions, ZnO-bulk and ZnO-NPs treated Allium cepa roots","volume":"7","author":"Ahmed","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2025.03.004_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/942916","article-title":"Mechanisms of nanoparticle-induced oxidative stress and toxicity","volume":"2013","author":"Manke","year":"2013","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.shaw.2013.07.006","article-title":"Oxidative DNA damage from nanoparticle exposure and its application to workers' health: a literature review","volume":"4","author":"Rim","year":"2013","journal-title":"Safe Health Work"},{"key":"10.1016\/j.jtos.2025.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.105046","article-title":"Cellular uptake and toxicity of gold nanoparticles on two distinct hepatic cell models","volume":"70","author":"Enea","year":"2021","journal-title":"Toxicol Vitro"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib54","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cclet.2019.04.048","article-title":"Core-shell lipid-polymer nanoparticles as a promising ocular drug delivery system to treat glaucoma","volume":"31","author":"Zhou","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.jtos.2025.03.004_bib55","article-title":"Nano-in-Nano dendrimer gel particles for efficient topical delivery of antiglaucoma drugs into the eye","volume":"425","author":"Wang","year":"2021","journal-title":"Chem Eng J"},{"key":"10.1016\/j.jtos.2025.03.004_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymertesting.2023.108292","article-title":"Lipid-nanoparticles-based co-delivery of black phosphorus quantum dots and melphalan by photothermal therapy combined with chemotherapy for retinoblastoma","volume":"129","author":"Wang","year":"2023","journal-title":"Polym Test"},{"key":"10.1016\/j.jtos.2025.03.004_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102419","article-title":"Subconjunctival delivery of sorafenib-tosylate-loaded cubosomes for facilitated diabetic retinopathy treatment: formulation development, evaluation, pharmacokinetic and pharmacodynamic (PKPD) studies","author":"Madhusudhan","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13346-020-00733-4","article-title":"Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)","volume":"10","author":"Yadav","year":"2020","journal-title":"Drug Delivery Translat Res"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jtos.2018.05.004","article-title":"Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis","volume":"16","author":"Lin","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"J Contr Release"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome\u2013chitosan nanoparticle complexes (LCS-NP)","volume":"28","author":"Diebold","year":"2007","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08982104.2016.1191022","article-title":"Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation","volume":"27","author":"Khalil","year":"2017","journal-title":"J Liposome Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib63","article-title":"In vitro and in vivo biological assessment of dual drug-loaded coaxial nanofibers for the treatment of corneal abrasion","volume":"604","author":"Tawfik","year":"2021","journal-title":"Int J Pharm (Amst)"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib64","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1021\/acs.molpharmaceut.8b00516","article-title":"Encapsulation of azithromycin ion pair in liposome for enhancing ocular delivery and therapeutic efficacy on dry eye","volume":"15","author":"Ren","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib65","unstructured":"P.H. Kolb, O.P.L.H. Kolb, I.P.L.H. Kolb, A.A.C.M. Farsaii, V.P. Connaughton, S.-c.P.H. Kolb, F.L.H. Kolb, G.R.H. Qian, C.V.P. Gouras, V.A.M. Kalloniatis, Gross anatomy of the eye. Eduardo Fernandez...."},{"key":"10.1016\/j.jtos.2025.03.004_bib66","first-page":"635","article-title":"Potential of gene editing and induced pluripotent stem cells (iPSCs) in treatment of retinal diseases","volume":"90","author":"Chuang","year":"2017","journal-title":"Yale J Biol Med"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib68","series-title":"Anatomy and physiology of the eye","first-page":"73","author":"Ita","year":"2022"},{"key":"10.1016\/j.jtos.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1569-2590(05)10005-6","article-title":"Ciliary body and ciliary epithelium","volume":"10","author":"Delamere","year":"2005","journal-title":"Adv Organ Biol"},{"key":"10.1016\/j.jtos.2025.03.004_bib70","series-title":"Glaucoma, IntechOpen, rijeka","article-title":"Anatomy of ciliary body, ciliary processes, anterior chamber angle and collector vessels","author":"Adriana Silva Borges","year":"2013"},{"key":"10.1016\/j.jtos.2025.03.004_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clindermatol.2014.10.006","article-title":"Human ocular anatomy","volume":"33","author":"Kels","year":"2015","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","article-title":"Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists","volume":"55","author":"Sheppard","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib74","unstructured":"H.Y. Kim, J.D. Lee, H. Kim, Y. Kim, J.J. Park, S.B. Oh, H. Goo, K.J. Cho, K.-B. Kim, Mass spectrometry (MS)-based metabolomics of plasma and urine in dry eye disease (DED)-induced rat model, J Toxicol Environ Health, Part A 1-14...."},{"key":"10.1016\/j.jtos.2025.03.004_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1077669","article-title":"Diabetic retinopathy: looking forward to 2030","volume":"13","author":"Tan","year":"2023","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/antiox12071379","article-title":"Oxidative stress and antioxidants in age-related macular degeneration","volume":"12","author":"Kushwah","year":"2023","journal-title":"Antioxidants"},{"issue":"10414","key":"10.1016\/j.jtos.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037648","article-title":"Eye health and quality of life: an umbrella review protocol","volume":"10","author":"Assi","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","article-title":"A global assessment of eye health and quality of life: a systematic review of systematic reviews","volume":"139","author":"Assi","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.03.004_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"17","key":"10.1016\/j.jtos.2025.03.004_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713211","article-title":"The association between vascular abnormalities and glaucoma-what comes first?","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/APO.0000000000000181","article-title":"Update on the medical treatment of primary open-angle glaucoma","volume":"5","author":"Cheema","year":"2016","journal-title":"Asia-Pacific J Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib84","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14656566.2017.1328498","article-title":"Topical treatment of glaucoma: established and emerging pharmacology","volume":"18","author":"Dikopf","year":"2017","journal-title":"Expet Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib85","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib86","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib87","first-page":"473","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med Clin"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib88","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib89","first-page":"Cd000254","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration","volume":"9","author":"Evans","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2018.07.028","article-title":"Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American academy of ophthalmology","volume":"126","author":"Bakri","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/13816810.2015.1016241","article-title":"High risk retinoblastoma: prevalence and success of treatment in developing countries","volume":"36","author":"ElZomor","year":"2015","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099036","article-title":"Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development","volume":"9","author":"Corson","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","article-title":"Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation","volume":"14","author":"Kropp","year":"2023","journal-title":"EPMA J"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib94","article-title":"Laser treatment modalities for diabetic retinopathy","volume":"14","author":"Pande","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib95","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis","volume":"10","author":"Virgili","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib96","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00417-023-06134-w","article-title":"Refining vitrectomy for proliferative diabetic retinopathy","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib97","article-title":"Recent advances in the treatment and delivery system of diabetic retinopathy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jtos.2025.03.004_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2023.07.055","article-title":"Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery","volume":"361","author":"Qi","year":"2023","journal-title":"J Contr Release"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib99","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib101","article-title":"A comprehensive review on dry eye disease: diagnosis, medical management, recent developments, and future challenges","volume":"2015","author":"Phadatare","year":"2015","journal-title":"Adv Pharmaceut"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib102","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.aopr.2024.01.008","article-title":"Recent progress of nanomedicine in managing dry eye disease","volume":"4","author":"Lv","year":"2024","journal-title":"Adv Ophthalmol Pract Res"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib104","article-title":"Medical interventions for fungal keratitis","volume":"2015","author":"FlorCruz","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib105","article-title":"Candida tropicalis fungal keratitis: a case report and literature review","volume":"16","author":"Adadi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jtos.2025.03.004_bib106","series-title":"Contact lens related microbial keratitis. literature review","author":"Manafli","year":"2023"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib107","article-title":"A review of contact lens-related risk factors and complications","volume":"14","author":"Waghmare","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jtos.2025.03.004_bib108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OPTH.S447138","article-title":"Fungal keratitis: diagnosis, management, and recent advances","volume":"18","author":"Awad","year":"2024","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib109","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijpharm.2018.10.057","article-title":"Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies","volume":"553","author":"Younes","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib110","series-title":"Conjunctivitis, StatPearls","author":"Hashmi","year":"2024"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib111","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5114\/pdia.2015.48071","article-title":"Adverse events in allergy sufferers wearing contact lenses","volume":"32","author":"Urgacz","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib112","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18502\/jovr.v15i3.7456","article-title":"Conjunctivitis: a systematic review","volume":"15","author":"Azari","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"issue":"16","key":"10.1016\/j.jtos.2025.03.004_bib113","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: a systematic review of diagnosis and treatment","volume":"310","author":"Azari","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jtos.2025.03.004_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J Contr Release"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0110-5558.72419","article-title":"Ocular inserts - advancement in therapy of eye diseases","volume":"1","author":"Kumari","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib116","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.2600680606","article-title":"Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits","volume":"68","author":"Lee","year":"1979","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib117","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"14","key":"10.1016\/j.jtos.2025.03.004_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147692","article-title":"The impact of diet and exercise on drug responses","volume":"22","author":"Niederberger","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7542929","article-title":"Review: the lacrimal gland and its role in dry eye","volume":"2016","author":"Conrady","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv Colloid Interface Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib121","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1080\/10717544.2022.2103600","article-title":"Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: preparation, in vitro characterization, ex vivo and in vivo assessments","volume":"29","author":"Ahmed","year":"2022","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib122","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exer.2011.06.004","article-title":"Molecular mechanisms underlying the corneal endothelial pump","volume":"95","author":"Bonanno","year":"2012","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061646","article-title":"Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships","volume":"15","author":"Santana","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080704","article-title":"Enhanced corneal penetration of a poorly permeable drug using bioadhesive multiple microemulsion technology","volume":"12","author":"Ibrahim","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23810","article-title":"Overview of processed excipients in ocular drug delivery: opportunities so far and bottlenecks","volume":"10","author":"Ashique","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jtos.2025.03.004_bib126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-0716-3429-5_17","article-title":"An in vitro bilayer model of human primary retinal pigment epithelial and choroid endothelial cells for permeability studies","volume":"2711","author":"Palanisamy","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtos.2025.03.004_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115006","article-title":"Recent advances of smart materials for ocular drug delivery","volume":"200","author":"Wang","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib128","article-title":"The utility and risks of therapeutic nanotechnology in the retina","volume":"13","author":"Scheive","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/2405461508666230801095201","article-title":"Overcoming the therapeutic limitation of ocular drug delivery with the help of novel drug carriers","volume":"10","author":"Shadab","year":"2025","journal-title":"Curr Nanomater"},{"issue":"20","key":"10.1016\/j.jtos.2025.03.004_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2017.07.035","article-title":"Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions","volume":"268","author":"Lalu","year":"2017","journal-title":"J Contr Release"},{"key":"10.1016\/j.jtos.2025.03.004_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/gels9070523","article-title":"Polymer-based hydrogels applied in drug delivery: an overview","author":"Thang","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.jtos.2025.03.004_bib133","article-title":"Recent developments in stimuli-responsive polymer for emerging applications: a review","volume":"25","author":"Khalil","year":"2025","journal-title":"Res Eng"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040511","article-title":"Vesicular drug delivery systems: promising approaches in ocular drug delivery","volume":"17","author":"Batur","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10.1016\/j.jtos.2025.03.004_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179668","article-title":"Current advances in specialised niosomal drug delivery: manufacture, characterization and drug delivery applications","volume":"23","author":"Witika","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib136","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.3390\/ijms24129824","article-title":"Development of phytochemical delivery systems by nano-suspension and nano-emulsion techniques","volume":"24","author":"Zuccari","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib137","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1080\/10717544.2022.2120926","article-title":"Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management","volume":"29","author":"Ahmed","year":"2022","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib138","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12551-023-01089-y","article-title":"A short review on the applicability and use of cubosomes as nanocarriers","volume":"15","author":"Palma","year":"2023","journal-title":"Biophys Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib139","article-title":"Investigating the efficacy of liquid crystal nano cubosomes containing dorzolamide and timolol for drug delivery to the cornea","volume":"106","author":"Nezhad","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113532","article-title":"PNIPAM-stabilized cubosomes as fusogenic delivery nanovectors for anticancer applications","volume":"231","author":"Balestri","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112524","article-title":"Self-assembled bilosomes with stimuli-responsive properties as bioinspired dual-tunable nanoplatform for pH\/temperature-triggered release of hybrid cargo","volume":"215","author":"Waglewska","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib142","article-title":"Lipid-based nanocarriers for ocular drug delivery: an updated review","volume":"76","author":"Das","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib143","article-title":"Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies","volume":"607","author":"Mofidfar","year":"2021","journal-title":"Int J Pharm (Amst)"},{"key":"10.1016\/j.jtos.2025.03.004_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109006","article-title":"Topical ocular drug delivery systems: innovations for an unmet need","volume":"218","author":"Yang","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib145","article-title":"Overview of recent advances in nano-based ocular drug delivery","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib146","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Nanomicelles: types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib147","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","article-title":"New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"43","author":"Li","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib148","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/OPTH.S181997","article-title":"Treatment-resistant bacterial keratitis: challenges and solutions","volume":"14","author":"Egrilmez","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib149","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S329831","article-title":"Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective","author":"Zhang","year":"2021","journal-title":"Int J Nanomed"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102514","article-title":"Natural polymer-based hydrogels: from polymer to biomedical applications","volume":"15","author":"Zhao","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib151","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib152","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijbiomac.2021.09.069","article-title":"Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration","volume":"191","author":"Suri","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib153","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1208\/s12249-020-01836-4","article-title":"Nanodelivery of resveratrol-loaded PLGA nanoparticles for age-related macular degeneration","volume":"21","author":"Bhatt","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","article-title":"Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers","volume":"2","author":"Cabral","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/IJG.0000000000001894","article-title":"Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations","volume":"30","author":"Levin","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jtos.2025.03.004_bib156","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2021.05.035","article-title":"Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration","volume":"335","author":"Kambhampati","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.jtos.2025.03.004_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112113","article-title":"Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis","volume":"208","author":"Ch","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120900","article-title":"A non-invasive nanoparticle-based sustained dual-drug delivery system as an eyedrop for endophthalmitis","volume":"606","author":"Mahaling","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118217","article-title":"Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration","volume":"267","author":"Pandit","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jtos.2025.03.004_bib160","series-title":"Quantum dots: their unique properties and contemporary applications","author":"Ebeid","year":"2024"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib161","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jop.2019.0108","article-title":"Bevacizumab-conjugated quantum dots: in vitro antiangiogenic potential and biosafety in rat retina","volume":"36","author":"Santana","year":"2020","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"null","key":"10.1016\/j.jtos.2025.03.004_bib162","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/IJN.S445398","article-title":"Utilization of nitrogen-doped graphene quantum dots to neutralize ROS and modulate intracellular antioxidant pathways to improve dry eye disease therapy","volume":"19","author":"Wu","year":"2024","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2025.03.004_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.705886","article-title":"Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol","volume":"9","author":"Nakhaei","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2023.101057","article-title":"Enhancement of liposomal properties of thyme essential oil using lysozyme modification: physicochemical, storage, and antibacterial properties","volume":"20","author":"Zhou","year":"2023","journal-title":"Food Chem X"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib167","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1081\/CLT-100102451","article-title":"Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists","volume":"37","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102154","article-title":"Lipid-based eye drop formulations for the management of evaporative dry eyes","volume":"47","author":"Maulvi","year":"2024","journal-title":"Contact Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib169","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13346-021-00912-x","article-title":"Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I\/II clinical trial","volume":"12","author":"Wong","year":"2022","journal-title":"Drug Delivery Translat Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2009.01.001","article-title":"Topical use of Coenzyme Q(10)-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect","volume":"372","author":"Zhang","year":"2009","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib171","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/10717544.2014.991952","article-title":"Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes","volume":"23","author":"Lin","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2025.03.004_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107805","article-title":"Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops","volume":"188","author":"Cheng","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109518","article-title":"Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases","volume":"136","author":"Suri","year":"2020","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib174","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/02713683.2020.1728777","article-title":"Anti-microbial effect and in vivo ocular delivery of ciprofloxacin-loaded liposome through rabbit's eye","volume":"45","author":"Feghhi","year":"2020","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/polym15030782","article-title":"Coating materials to increase the stability of liposomes","author":"Pasarin","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.jtos.2025.03.004_bib176","article-title":"Opportunities and challenges in commercial pharmaceutical liposome applications","volume":"154\u2013155","author":"Jensen","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11020055","article-title":"Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery","volume":"11","author":"Ge","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib178","article-title":"Niosomes for nose-to-brain delivery: a non-invasive versatile carrier system for drug delivery in neurodegenerative diseases","volume":"89","author":"Al Jayoush","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"49","key":"10.1016\/j.jtos.2025.03.004_bib179","doi-asserted-by":"crossref","first-page":"33265","DOI":"10.1021\/acsomega.1c05083","article-title":"Nanoarchitectonics of multifunctional niosomes for advanced drug delivery","volume":"6","author":"Momekova","year":"2021","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041247","article-title":"Formulation and characterization of epalrestat-loaded polysorbate 60 cationic niosomes for ocular delivery","volume":"15","author":"Kattar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib181","article-title":"Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma","volume":"598","author":"Allam","year":"2021","journal-title":"Int J Pharm (Amst)"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib182","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/03639045.2020.1755305","article-title":"Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma","volume":"46","author":"Fathalla","year":"2020","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib183","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2015.07.007","article-title":"Dexamethasone nanowafer as an effective therapy for dry eye disease","volume":"213","author":"Coursey","year":"2015","journal-title":"J Contr Release"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib184","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib185","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2025.03.004_bib186","article-title":"Improvement of PnPP-19 peptide bioavailability for glaucoma therapy: design and application of nanowafers based on PVA","volume":"74","author":"Dourado","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib187","series-title":"Broadly applicable nanowafer drug delivery system for treating eye injuries","author":"Stephen","year":"2017"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib188","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/bioengineering9080384","article-title":"Investigation of factors influencing formation of nanoemulsion by spontaneous emulsification: impact on droplet size, polydispersity index, and stability","volume":"9","author":"Algahtani","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.jtos.2025.03.004_bib189","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J Contr Release"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib190","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1080\/02713683.2021.1929328","article-title":"Acyclovir-loaded nanoemulsions: preparation, characterization and irritancy studies for ophthalmic delivery","volume":"46","author":"Mohammadi","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119402","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic\/pharmacodynamic properties","volume":"583","author":"Ismail","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib192","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40824-020-0184-8","article-title":"Emerging role of nanosuspensions in drug delivery systems","volume":"24","author":"Jacob","year":"2020","journal-title":"Biomater Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106425","article-title":"Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate","volume":"185","author":"Ma","year":"2023","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib194","doi-asserted-by":"crossref","first-page":"E192","DOI":"10.1208\/pt070127","article-title":"Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene","volume":"7","author":"Pignatello","year":"2006","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/02652048.2010.523794","article-title":"Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery","volume":"28","author":"Ahuja","year":"2011","journal-title":"J Microencapsul"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib196","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1166\/jbn.2013.1475","article-title":"Development and characterization of pilocarpine loaded Eudragit nanosuspensions for ocular drug delivery","volume":"9","author":"Khan","year":"2013","journal-title":"J Biomed Nanotechnol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib197","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/2211738507666190405182524","article-title":"Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs","volume":"7","author":"Joshi","year":"2019","journal-title":"Pharm Nanotechnol"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib198","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.03.048","article-title":"Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo","volume":"467","author":"Tuomela","year":"2014","journal-title":"Int J Pharm (Amst)"},{"key":"10.1016\/j.jtos.2025.03.004_bib199","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2016.07.005","article-title":"Development of cationic nanocrystals for ocular delivery","volume":"107","author":"Romero","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijbiomac.2018.11.217","article-title":"Effect of cellulose nanocrystals on the performance of drug loaded in situ gelling thermo-responsive ophthalmic formulations","volume":"124","author":"Orasugh","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jtos.2025.03.004_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111753","article-title":"Bicontinuous cubic liquid crystalline phase nanoparticles stabilized by softwood hemicellulose","volume":"203","author":"Naidjonoka","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejpb.2016.05.001","article-title":"Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood\u2013brain barrier","volume":"104","author":"Azhari","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib203","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jddst.2019.04.036","article-title":"Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study","volume":"52","author":"Eldeeb","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib204","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ijpharm.2018.10.057","article-title":"Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies","volume":"553","author":"Younes","year":"2018","journal-title":"Int J Pharm (Amst)"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11095-020-02857-1","article-title":"Preparation and evaluation of cubosomes\/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis","volume":"37","author":"Gaballa","year":"2020","journal-title":"Pharm Res"},{"issue":"49","key":"10.1016\/j.jtos.2025.03.004_bib206","doi-asserted-by":"crossref","first-page":"18167","DOI":"10.1021\/acssuschemeng.0c06549","article-title":"Synergistic effect of the oleic acid and oleylamine mixed-liquid matrix on particle size and stability of sputtered metal nanoparticles","volume":"8","author":"Nguyen","year":"2020","journal-title":"ACS Sustainable Chem Eng"},{"key":"10.1016\/j.jtos.2025.03.004_bib207","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2019.01.070","article-title":"Mucoadhesive olaminosomes: a novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension","volume":"560","author":"Abd-Elsalam","year":"2019","journal-title":"Int J Pharm (Amst)"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081291","article-title":"Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery platform-A comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib209","doi-asserted-by":"crossref","DOI":"10.3390\/jfb14090437","article-title":"Lipid\u2013polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery","author":"Jain","year":"2023","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.jtos.2025.03.004_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110695","article-title":"Polymer-hybrid nanoparticles: current advances in biomedical applications","volume":"131","author":"Ferreira Soares","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib211","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1021\/acsnano.1c00680","article-title":"Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles","volume":"15","author":"Li","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2025.03.004_bib212","doi-asserted-by":"crossref","DOI":"10.3390\/polym15224369","article-title":"Dendrimers: exploring their wide structural variety and applications","author":"P\u00e9rez-Ferreiro","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.jtos.2025.03.004_bib213","first-page":"1","article-title":"Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications","volume":"11","author":"Kalomiraki","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2025.03.004_bib214","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jconrel.2022.04.008","article-title":"Dendrimer as a momentous tool in tissue engineering and regenerative medicine","volume":"346","author":"Shaikh","year":"2022","journal-title":"J Contr Release"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib215","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acsbiomaterials.7b00319","article-title":"Fast dissolving dendrimer nanofiber mats as alternative to eye drops for more efficient antiglaucoma drug delivery","volume":"3","author":"Lancina","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib216","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.11.043","article-title":"Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits","volume":"461","author":"Mishra","year":"2014","journal-title":"Int J Pharm (Amst)"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib217","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2011.08.018","article-title":"Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs","volume":"8","author":"Holden","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib218","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113419","article-title":"Topical astodrimer sodium, a non-toxic polyanionic dendrimer, demonstrates antiviral activity in an experimental ocular adenovirus infection model","volume":"26","author":"Romanowski","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jtos.2025.03.004_bib219","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2021.05.035","article-title":"Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration","volume":"335","author":"Kambhampati","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.jtos.2025.03.004_bib220","article-title":"Nano-in-Nano dendrimer gel particles for efficient topical delivery of antiglaucoma drugs into the eye","volume":"425","author":"Wang","year":"2021","journal-title":"Chem Eng J"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib221","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1007\/s13346-023-01503-8","article-title":"Magnetic targeting of lornoxicam\/SPION bilosomes loaded in a thermosensitive in situ hydrogel system for the management of osteoarthritis: optimization, in vitro, ex vivo, and in vivo studies in rat model via modulation of RANKL\/OPG","volume":"14","author":"Ibrahiem","year":"2024","journal-title":"Drug Delivery Translat Res"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib222","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int J Pharm (Amst)"},{"key":"10.1016\/j.jtos.2025.03.004_bib223","article-title":"Fabrication of betaxolol hydrochloride-loaded highly permeable ocular bilosomes (HPOBs) to combat glaucoma: in vitro, ex vivo & in vivo characterizations","volume":"82","author":"Sakr","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib224","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. Nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s42452-024-05897-z","article-title":"Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies\u2014a comprehensive review","volume":"6","author":"Bukke","year":"2024","journal-title":"Discover App Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib226","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.msec.2019.03.060","article-title":"Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: characterization, pharmacokinetic and deposition study","volume":"100","author":"Ahmad","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/nano9010033","article-title":"In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: tear kinetics and ocular disposition studies","volume":"9","author":"Tatke","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtos.2025.03.004_bib228","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib229","article-title":"Solidified nanostructured lipid carrier (S-NLC) for enhancing the oral bioavailability of ezetimibe","volume":"53","author":"Shevalkar","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib230","article-title":"Nanostructured lipid carriers as a drug delivery system: a comprehensive review with therapeutic applications","author":"Mall","year":"2024","journal-title":"Intell Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib231","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijbiomac.2018.01.120","article-title":"Biological macromolecules for ophthalmic drug delivery to treat ocular diseases","volume":"110","author":"Krishnaswami","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib232","first-page":"423","article-title":"A hybrid genipin-crosslinked dual-sensitive hydrogel\/nanostructured lipid carrier ocular drug delivery platform","volume":"14","author":"Yu","year":"2019","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib233","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2019.01.038","article-title":"Mammalian near-infrared image vision through injectable and self-powered retinal nanoantennae","volume":"177","author":"Ma","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib234","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1039\/D2RA06023J","article-title":"Electrospun nanofibres in drug delivery: advances in controlled release strategies","volume":"13","author":"Gaydhane","year":"2023","journal-title":"RSC Adv"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13205-024-04135-y","article-title":"Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery","volume":"14","author":"Basu","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.jtos.2025.03.004_bib236","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejpb.2019.05.010","article-title":"Ocular biocompatibility of dexamethasone acetate loaded poly(\u025b-caprolactone) nanofibers","volume":"142","author":"Da Silva","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"30","key":"10.1016\/j.jtos.2025.03.004_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302909","article-title":"Retinal microenvironment-protected rhein-GFFYE nanofibers attenuate retinal ischemia-reperfusion injury via inhibiting oxidative stress and regulating microglial\/macrophage M1\/M2 polarization","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib238","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041296","article-title":"Formulation and characterization of electrospun nanofibers for melatonin ocular delivery","volume":"15","author":"Romeo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib239","article-title":"In-situ tear fluid dissolving nanofibers enable prolonged viscosity-enhanced dual drug delivery to the eye","volume":"616","author":"Rohde","year":"2022","journal-title":"Int J Pharm (Amst)"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib240","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041264","article-title":"Peptide nanofiber system for sustained delivery of anti-VEGF proteins to the eye vitreous","volume":"15","author":"Yaylaci","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib241","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.actbio.2023.01.016","article-title":"An electrospun scaffold functionalized with a ROS-scavenging hydrogel stimulates ocular wound healing","volume":"158","author":"Shi","year":"2023","journal-title":"Acta Biomater"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib242","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1021\/acsnano.9b02305","article-title":"Gas-permeable, irritation-free, transparent hydrogel contact lens devices with metal-coated nanofiber mesh for eye interfacing","volume":"13","author":"Wei","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2025.03.004_bib243","article-title":"Gold nanoparticles in ophthalmology","volume":"39","author":"Masse","year":"2018","journal-title":"Med Res Rev"},{"issue":"50","key":"10.1016\/j.jtos.2025.03.004_bib244","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/20\/50\/505101","article-title":"Intravenously administered gold nanoparticles pass through the blood\u2013retinal barrier depending on the particle size, and induce no retinal toxicity","volume":"20","author":"Kim","year":"2009","journal-title":"Nanotechnology"},{"issue":"19","key":"10.1016\/j.jtos.2025.03.004_bib245","doi-asserted-by":"crossref","DOI":"10.3390\/polym13193324","article-title":"Hyaluronic acid-based gold nanoparticles for the topical delivery of therapeutics to the retina and the retinal pigment epithelium","volume":"13","author":"Laradji","year":"2021","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib246","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2204206","article-title":"Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment","volume":"30","author":"Jiang","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtos.2025.03.004_bib247","article-title":"Mesoporous silica decorated with gold nanoparticles as a promising nanoprobe for effective CT X-ray attenuation and potential drug delivery","volume":"26","author":"Mulikova","year":"2021","journal-title":"Nano-Struct Nano-Obj"},{"key":"10.1016\/j.jtos.2025.03.004_bib248","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.0c01347","article-title":"Emerging trends in nanomedicine for improving ocular drug delivery: light-responsive nanoparticles, mesoporous silica nanoparticles, and contact lenses","volume":"6","author":"Rodrigues","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib249","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0885328220977605","article-title":"Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus","volume":"35","author":"Paiva","year":"2021","journal-title":"J Biomater Appl"},{"key":"10.1016\/j.jtos.2025.03.004_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108124","article-title":"Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts","volume":"197","author":"Wu","year":"2020","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202205754","article-title":"Functional carbon quantum dots for ocular imaging and therapeutic applications","volume":"19","author":"Kumar","year":"2023","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib252","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.11.9.1","article-title":"Carbon nanostructures for ocular tissue reinforcement","volume":"11","author":"Silvestre","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.matlet.2024.137642","article-title":"Ocular drug delivery strategies using carbon nanotubes: a perspective","volume":"379","author":"Sonowal","year":"2025","journal-title":"Mater Lett"},{"key":"10.1016\/j.jtos.2025.03.004_bib254","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3390\/ijms21082957","article-title":"Graphene oxide\u2013based nanomaterials: an insight into retinal prosthesis","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib255","article-title":"Timolol-eluting graphene oxide laden silicone contact lens: control release profile with improved critical lens properties","volume":"69","author":"Maulvi","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jtos.2025.03.004_bib256","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","article-title":"Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels","volume":"141","author":"Lin","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtos.2025.03.004_bib257","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.addr.2019.10.006","article-title":"Nanotechnology in regenerative ophthalmology","volume":"148","author":"Sahle","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112044","article-title":"Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy","volume":"208","author":"Chadar","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib259","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2147\/IJN.S299448","article-title":"Carbon nanotubes: smart drug\/gene delivery carriers","volume":"16","author":"Zare","year":"2021","journal-title":"Int J Nanomed"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib260","doi-asserted-by":"crossref","first-page":"446","DOI":"10.18502\/jovr.v15i4.7778","article-title":"Penetration of carbon nanotubes into the retinoblastoma tumor after intravitreal injection in LH [... Formula...] T [... Formula...] transgenic mice reti-noblastoma model","volume":"15","author":"Demirci","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102117","article-title":"Nanomaterials in the diagnosis and treatment of ophthalmic diseases","volume":"54","author":"Ma","year":"2024","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib262","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.2023.0083","article-title":"Nanotechnology in retinal disease: current concepts and future directions","volume":"40","author":"Mehta","year":"2024","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"14","key":"10.1016\/j.jtos.2025.03.004_bib263","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2217\/nnm-2018-0299","article-title":"Gold nanoparticles for multimodal high-resolution imaging of transplanted cells for retinal replacement therapy","volume":"14","author":"Chemla","year":"2019","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib264","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/ten.tec.2019.0136","article-title":"Magnetic iron oxide nanoparticle labeling of photoreceptor precursors for magnetic resonance imaging","volume":"25","author":"Ma","year":"2019","journal-title":"Tissue Eng C Methods"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib265","article-title":"Optical coherence tomography (OCT): a brief look at the uses and technological evolution of ophthalmology","volume":"59","author":"Zeppieri","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib266","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1039\/D0BM01063D","article-title":"Gold nanoparticles to enhance ophthalmic imaging","volume":"9","author":"Chen","year":"2021","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib267","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1038\/s41598-019-42324-5","article-title":"Contrast agent enhanced multimodal photoacoustic microscopy and optical coherence tomography for imaging of rabbit choroidal and retinal vessels in vivo","volume":"9","author":"Nguyen","year":"2019","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jtos.2025.03.004_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26185577","article-title":"Soft contact lenses as drug delivery systems: a review","volume":"26","author":"Rykowska","year":"2021","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.jtos.2025.03.004_bib269","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.3390\/app10155151","article-title":"Contact lenses as drug delivery system for glaucoma: a review","volume":"10","author":"Peral","year":"2020","journal-title":"Appl Sci"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib270","article-title":"Therapeutic contact lenses with polymeric vehicles for ocular drug delivery","volume":"11","author":"Choi","year":"2018","journal-title":"A Review, Materials (Basel)"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib271","article-title":"Contact lens as an emerging platform for ophthalmic drug delivery: a systematic review","volume":"18","author":"Yang","year":"2023","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib272","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13111571","article-title":"Advances in therapeutic contact lenses for the management of different ocular conditions","volume":"13","author":"Ioni\u021b\u0103","year":"2023","journal-title":"J Personalized Med"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib273","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/ICO.0000000000002711","article-title":"Dexamethasone-Eluting contact lens for the prevention of postphotorefractive keratectomy scar in a New Zealand white rabbit model","volume":"40","author":"Soeken","year":"2021","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib274","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/02713683.2019.1705492","article-title":"Preparation, characterization, and evaluation of zinc oxide nanoparticles suspension as an antimicrobial media for daily use soft contact lenses","volume":"45","author":"Shayani Rad","year":"2020","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2018.09.011","article-title":"Phomopsidione nanoparticles coated contact lenses reduce microbial keratitis causing pathogens","volume":"178","author":"Bin Sahadan","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119314","article-title":"Drug-free contact lens based on quaternized chitosan and tannic acid for bacterial keratitis therapy and corneal repair","volume":"286","author":"Jiao","year":"2022","journal-title":"Carbohydr Polym"},{"issue":"41","key":"10.1016\/j.jtos.2025.03.004_bib277","doi-asserted-by":"crossref","first-page":"45789","DOI":"10.1021\/acsami.0c12667","article-title":"Soft contact lens with embedded microtubes for sustained and self-adaptive drug delivery for glaucoma treatment","volume":"12","author":"Ding","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib278","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092902","article-title":"Hydrogels: properties and applications in biomedicine","volume":"27","author":"Ho","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib279","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/2230-973X.100042","article-title":"Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride","volume":"2","author":"Mandal","year":"2012","journal-title":"Int J Pharm Investig"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib280","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.drudis.2019.03.022","article-title":"Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases","volume":"24","author":"Arranz-Romera","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtos.2025.03.004_bib281","doi-asserted-by":"crossref","DOI":"10.3390\/polym14122359","article-title":"Intravitreal injectable hydrogels for sustained drug delivery in glaucoma treatment and therapy","author":"Akulo","year":"2022","journal-title":"Polymers"},{"issue":"43","key":"10.1016\/j.jtos.2025.03.004_bib282","doi-asserted-by":"crossref","first-page":"39603","DOI":"10.1021\/acsami.9b13851","article-title":"Overcoming the anatomical and physiological barriers in topical eye surface medication using a peptide-decorated polymeric micelle","volume":"11","author":"Lin","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jtos.2025.03.004_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118889","article-title":"\u03b3-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis","volume":"277","author":"Fang","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jtos.2025.03.004_bib284","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jconrel.2022.10.036","article-title":"Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space","volume":"352","author":"Jung","year":"2022","journal-title":"J Contr Release"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib285","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204994","article-title":"Injectable anti-inflammatory supramolecular nanofiber hydrogel to promote anti-VEGF therapy in age-related macular degeneration treatment","volume":"35","author":"Gao","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.jtos.2025.03.004_bib286","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115082","article-title":"Microneedles for advanced ocular drug delivery","volume":"201","author":"Glover","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116907","article-title":"Applications of microneedles in delivering drugs for various ocular diseases","volume":"237","author":"Gupta","year":"2019","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib288","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11095-008-9756-3","article-title":"Intrascleral drug delivery to the eye using hollow microneedles","volume":"26","author":"Jiang","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib289","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.698780","article-title":"Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020)","volume":"11","author":"Ahmadikia","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib290","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202104657","article-title":"A rapid corneal healing microneedle for efficient ocular drug delivery","volume":"18","author":"Shi","year":"2022","journal-title":"Small"},{"issue":"21","key":"10.1016\/j.jtos.2025.03.004_bib291","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102327","article-title":"Ocular delivery of predatory bacteria with cryomicroneedles against eye infection","volume":"8","author":"Cui","year":"2021","journal-title":"Adv Sci"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib292","article-title":"Self-plugging microneedle (SPM) for intravitreal drug delivery","volume":"11","author":"Lee","year":"2022","journal-title":"Adv Healthcare Mater"},{"issue":"13","key":"10.1016\/j.jtos.2025.03.004_bib293","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1073\/pnas.0600559103","article-title":"Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision","volume":"103","author":"Ellis-Behnke","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.jtos.2025.03.004_bib294","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1021\/acsami.6b02419","article-title":"Development of omniphobic desalination membranes using a charged electrospun nanofiber scaffold","volume":"8","author":"Lee","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib295","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/j.1755-3768.2010.01982.x","article-title":"Redefining tissue engineering for nanomedicine in ophthalmology","volume":"89","author":"Ellis-Behnke","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib296","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.actbio.2015.03.016","article-title":"Micro- and nano-topography to enhance proliferation and sustain functional markers of donor-derived primary human corneal endothelial cells","volume":"19","author":"Muhammad","year":"2015","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtos.2025.03.004_bib297","doi-asserted-by":"crossref","DOI":"10.3390\/nano11081880","article-title":"Nano-biomaterials for retinal regeneration","author":"Sharma","year":"2021","journal-title":"Nanomaterials"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib298","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.12.007","article-title":"Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct","volume":"355","author":"Attama","year":"2008","journal-title":"Int J Pharm (Amst)"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib299","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/erd.09.39","article-title":"New directions in nanofibrous scaffolds for soft tissue engineering and regeneration","volume":"6","author":"Baker","year":"2009","journal-title":"Expet Rev Med Dev"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib300","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00210-022-02287-3","article-title":"Nanomedicine and drug delivery to the retina: current status and implications for gene therapy","volume":"395","author":"Tawfik","year":"2022","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jtos.2025.03.004_bib301","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/OPTH.S364200","article-title":"Ocular gene therapy: a literature review with special focus on immune and inflammatory responses","volume":"16","author":"Ghoraba","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib302","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib303","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib304","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"6372","key":"10.1016\/j.jtos.2025.03.004_bib305","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101756","article-title":"Gene therapy for chronic pain management","volume":"5","author":"Li","year":"2024","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib307","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-024-01851-7","article-title":"Customizable virus-like particles deliver CRISPR\u2013Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy","author":"Ling","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jtos.2025.03.004_bib308","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtn.2017.12.019","article-title":"Transcriptome profiling of neovascularized corneas reveals miR-204 as a multi-target biotherapy deliverable by rAAVs","volume":"10","author":"Lu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib309","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e318206c893","article-title":"Gene transfer using micellar nanovectors inhibits corneal neovascularization in vivo","volume":"30","author":"Iriyama","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2025.03.004_bib310","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical administration of SLN-based gene therapy for the treatment of corneal inflammation by de novo IL-10 production","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib311","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060845","article-title":"Neuroprotective effect of siRNA entrapped in hyaluronic acid-coated lipoplexes by intravitreal administration","volume":"13","author":"Ribeiro","year":"2021","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib312","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/nl502275s","article-title":"Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo","volume":"14","author":"Rajala","year":"2014","journal-title":"Nano Lett"},{"key":"10.1016\/j.jtos.2025.03.004_bib313","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.actbio.2022.11.016","article-title":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","volume":"155","author":"Ma","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jtos.2025.03.004_bib314","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132426","article-title":"cRGD-modified hybrid lipopolymeric nanoplexes for gene editing in the posterior segment of the eye","volume":"271","author":"Sahel","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib315","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.54755","article-title":"Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis","volume":"11","author":"Dong","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib316","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jtos.2025.03.004_bib317","first-page":"187","article-title":"Clinical and ocular inflammatory inhibitors of viral-based gene therapy of the retina","author":"Ohlhausen","year":"2024","journal-title":"Acta Microbiol Hell"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib318","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib319","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib320","article-title":"Gene therapy advances: a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib321","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"13","key":"10.1016\/j.jtos.2025.03.004_bib322","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1167\/iovs.12-10658","article-title":"Inhibition of choroidal and corneal pathologic neovascularization by Plgf1-de gene transfer","volume":"53","author":"Tarallo","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib323","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/btm2.10090","article-title":"How will the field of gene therapy survive its success?","volume":"3","author":"Kaemmerer","year":"2018","journal-title":"Bioeng Transl Med"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib324","doi-asserted-by":"crossref","DOI":"10.3390\/genes13081370","article-title":"Appraisal for the potential of viral and nonviral vectors in gene therapy: a review","volume":"13","author":"Butt","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib325","first-page":"Ge01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib326","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1566523221666210423084233","article-title":"Gene therapy in the anterior eye segment","volume":"22","author":"Amador","year":"2022","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib327","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1872211314666191224115211","article-title":"Nano-based drug delivery system: recent strategies for the treatment of ocular disease and future perspective","volume":"13","author":"Qamar","year":"2019","journal-title":"Recent Pat Drug Deliv Formulation"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib328","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib329","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","article-title":"Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b\/2 trial","volume":"28","author":"Russell","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib330","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00940","article-title":"Short hairpin RNAs for strand-specific small interfering RNA production","volume":"8","author":"Sheng","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib331","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.jtos.2025.03.004_bib332","article-title":"Non-viral gene therapy using RNA interference with PDGFR-\u03b1 mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy","volume":"20","author":"Wang","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.jtos.2025.03.004_bib333","first-page":"353","article-title":"Mechanism and applications of CRISPR\/Cas-9-Mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib334","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169931","article-title":"Non-homologous end joining and homology directed DNA repair frequency of double-stranded breaks introduced by genome editing reagents","volume":"12","author":"Zaboikin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2025.03.004_bib335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jare.2021.11.018","article-title":"The power and the promise of CRISPR\/Cas9 genome editing for clinical application with gene therapy","volume":"40","author":"Guo","year":"2022","journal-title":"J Adv Res"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib336","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41434-021-00258-6","article-title":"Restoration of RPGR expression in vivo using CRISPR\/Cas9 gene editing","volume":"29","author":"Gumerson","year":"2022","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtos.2025.03.004_bib337","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2022.04.015","article-title":"CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization","volume":"28","author":"Chung","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib338","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4252\/wjsc.v11.i11.937","article-title":"CRISPR\/Cas system: an emerging technology in stem cell research","volume":"11","author":"Valenti","year":"2019","journal-title":"World J Stem Cell"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib339","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib340","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib341","article-title":"Exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy","volume":"6","author":"Jella","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jtos.2025.03.004_bib342","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2023.100032","article-title":"Exosome as drug delivery system: current advancements","volume":"3","author":"Sharma","year":"2024","journal-title":"Extracell Vesicle"},{"key":"10.1016\/j.jtos.2025.03.004_bib343","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114899","article-title":"Advances in development of exosomes for ophthalmic therapeutics","volume":"199","author":"Tian","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib344","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13205-023-03521-2","article-title":"Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives","volume":"13","author":"Sen","year":"2023","journal-title":"3 Biotech"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib345","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","article-title":"Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells","volume":"5","author":"Tian","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib346","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj9617","article-title":"miR-204-containing exosomes ameliorate GVHD-associated dry eye disease","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib347","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121194","article-title":"Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery","volume":"12","author":"Buya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib348","volume":"70","author":"D","year":"2021","journal-title":"Int J Pharmaceut Sci Rev Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib349","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2147\/IJN.S408115","article-title":"Self-nanoemulsifying drug delivery system for enhanced bioavailability of madecassic acid: in vitro and in vivo evaluation","author":"Lin","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jtos.2025.03.004_bib350","article-title":"Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection","volume":"623","author":"L\u00f3pez-Cano","year":"2022","journal-title":"Int J Pharm (Amst)"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib351","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/smll.200400130","article-title":"Nanoscience, nanotechnology, and chemistry","volume":"1","author":"Whitesides","year":"2005","journal-title":"Small"},{"key":"10.1016\/j.jtos.2025.03.004_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111856","article-title":"Tailoring therapeutic properties of silver nanoparticles for effective bacterial keratitis treatment","volume":"205","author":"Nguyen","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib353","doi-asserted-by":"crossref","first-page":"18729","DOI":"10.1021\/acsnano.2c07444","article-title":"Cell wall destruction and internal cascade synergistic antifungal strategy for fungal keratitis","volume":"16","author":"Ye","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2025.03.004_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103200","article-title":"Intravitreal therapeutic nanoparticles for age-related macular degeneration: design principles, progress and opportunities","volume":"329","author":"Zhang","year":"2024","journal-title":"Adv Colloid Interface Sci"},{"issue":"7","key":"10.1016\/j.jtos.2025.03.004_bib355","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202400030","article-title":"Intracellular trafficking pathway and ROS scavenging activity of glycol chitosan\u2010coated cerium oxide nanoparticles in a pathological AMD\u2010like model","volume":"7","author":"Kwon","year":"2024","journal-title":"Adv Therapeut"},{"key":"10.1016\/j.jtos.2025.03.004_bib356","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtos.2025.03.004_bib357","doi-asserted-by":"crossref","DOI":"10.3390\/nano10010140","article-title":"Nanoparticles as anti-microbial, anti-inflammatory, and remineralizing agents in oral care cosmetics: a review of the current situation","author":"Carrouel","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtos.2025.03.004_bib358","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.biopha.2018.11.116","article-title":"Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review","volume":"109","author":"Agarwal","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"10.1016\/j.jtos.2025.03.004_bib359","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1167\/iovs.12-10743","article-title":"Effects of gold nanoparticles on endotoxin-induced uveitis in rats","volume":"53","author":"Pereira","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"35","key":"10.1016\/j.jtos.2025.03.004_bib360","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb7878","article-title":"Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation","volume":"6","author":"Ganugula","year":"2020","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib361","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12011-020-02556-3","article-title":"Involvement of TRPM2 channel on hypoxia-induced oxidative injury, inflammation, and cell death in retinal pigment epithelial cells: modulator action of selenium nanoparticles","volume":"199","author":"\u00d6zkaya","year":"2021","journal-title":"Biol Trace Elem Res"},{"issue":"43","key":"10.1016\/j.jtos.2025.03.004_bib362","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1039\/C9TB01066A","article-title":"Cytocompatible cerium oxide-mediated antioxidative stress in inhibiting ocular inflammation-associated corneal neovascularization","volume":"7","author":"Zheng","year":"2019","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.jtos.2025.03.004_bib363","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1269581","article-title":"From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration","volume":"14","author":"Afzal","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtos.2025.03.004_bib364","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7836828","article-title":"Role of oxidative stress in retinal disease and the early intervention strategies: a review","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jtos.2025.03.004_bib365","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102967","article-title":"Oxidative stress in the eye and its role in the pathophysiology of ocular diseases","volume":"68","author":"B\u00f6hm","year":"2023","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib366","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2025.03.004_bib367","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2019.10.039","article-title":"A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease","volume":"315","author":"Yu","year":"2019","journal-title":"J Contr Release"},{"issue":"45","key":"10.1016\/j.jtos.2025.03.004_bib368","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202102485","article-title":"Therapeutic nanoparticles from grape seed for modulating oxidative stress","volume":"17","author":"Wang","year":"2021","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib369","doi-asserted-by":"crossref","DOI":"10.3390\/nu11051002","article-title":"Dietary antioxidants, macular pigment, and glaucomatous neurodegeneration: a review of the evidence","volume":"11","author":"Lawler","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jtos.2025.03.004_bib370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119961","article-title":"Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy","volume":"243","author":"Luo","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtos.2025.03.004_bib371","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10040575","article-title":"Novel thiol containing hybrid antioxidant-nitric oxide donor small molecules for treatment of glaucoma","author":"Amankwa","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jtos.2025.03.004_bib372","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/608751","article-title":"Diabetic cataract-pathogenesis, epidemiology and treatment","volume":"2010","author":"Pollreisz","year":"2010","journal-title":"J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib373","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.nano.2016.12.021","article-title":"Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression","volume":"13","author":"Yang","year":"2017","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"27","key":"10.1016\/j.jtos.2025.03.004_bib374","doi-asserted-by":"crossref","first-page":"13126","DOI":"10.1039\/C9NR02350J","article-title":"Autoregenerative redox nanoparticles as an antioxidant and glycation inhibitor for palliation of diabetic cataracts","volume":"11","author":"Zhou","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jtos.2025.03.004_bib375","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030441","article-title":"Treatment of human lens epithelium with high levels of nanoceria leads to reactive oxygen species mediated apoptosis","author":"Hanafy","year":"2020","journal-title":"Molecules"},{"issue":"10153","key":"10.1016\/j.jtos.2025.03.004_bib376","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib377","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111743","article-title":"Dietary antioxidants in age-related macular degeneration and glaucoma","volume":"10","author":"Dziedziak","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jtos.2025.03.004_bib378","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2019.03.003","article-title":"Retinal long term neuroprotection by Cerium Oxide nanoparticles after an acute damage induced by high intensity light exposure","volume":"182","author":"Tisi","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib379","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071617","article-title":"Nanoceria particles are an eligible candidate to prevent age-related macular degeneration by inhibiting retinal pigment epithelium cell death and autophagy alterations","author":"Tisi","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib380","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtos.2025.03.004_bib381","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2147\/DDDT.S383101","article-title":"Progress and challenges of anti-VEGF agents and their sustained-release strategies for retinal angiogenesis","volume":"16","author":"Xu","year":"2022","journal-title":"Drug Des Dev Ther"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib382","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nano.2011.01.011","article-title":"Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge","volume":"7","author":"Arvizo","year":"2011","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"15","key":"10.1016\/j.jtos.2025.03.004_bib383","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1167\/iovs.16-19754","article-title":"The antiangiogenic effects of gold nanoparticles on experimental choroidal neovascularization in mice","volume":"57","author":"Roh","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib384","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102205","article-title":"Inhibition of choroidal neovascularization by systemic delivery of gold nanoparticles","volume":"28","author":"Singh","year":"2020","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib385","article-title":"The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells","author":"Chan","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib386","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2010.03.022","article-title":"Silver nano \u2014 a trove for retinal therapies","volume":"145","author":"Kalishwaralal","year":"2010","journal-title":"J Contr Release"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib387","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12951-022-01362-4","article-title":"Graphene quantum dots rescue angiogenic retinopathy via blocking STAT3\/Periostin\/ERK signaling","volume":"20","author":"Zhao","year":"2022","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib388","doi-asserted-by":"crossref","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jtos.2025.03.004_bib389","doi-asserted-by":"crossref","DOI":"10.1039\/D4PM00032C","article-title":"Antimicrobial nanoparticles: current landscape and future challenges","author":"Mondal","year":"2024","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib390","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/IJN.S121956","article-title":"The antimicrobial activity of nanoparticles: present situation and prospects for the future","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Nanomed"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib391","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032104","article-title":"Metallic nanosystems in the development of antimicrobial strategies with high antimicrobial activity and high biocompatibility","volume":"24","author":"Sk\u0142odowski","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.jtos.2025.03.004_bib392","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1021\/acsbiomaterials.1c00815","article-title":"Antimicrobial action of biocompatible silver microspheres and their role in the potential treatment of fungal keratitis","volume":"7","author":"Shi","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.jtos.2025.03.004_bib393","doi-asserted-by":"crossref","DOI":"10.3390\/toxics10030144","article-title":"Double-sided nano-ZnO: superior antibacterial properties and induced hepatotoxicity in zebrafish embryos","author":"He","year":"2022","journal-title":"Toxics"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib394","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/02713683.2019.1705492","article-title":"Preparation, characterization, and evaluation of zinc oxide nanoparticles suspension as an antimicrobial media for daily use soft contact lenses","volume":"45","author":"Shayani Rad","year":"2020","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib395","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1049\/nbt2.12085","article-title":"Diverse biotechnological applications of multifunctional titanium dioxide nanoparticles: an up-to-date review","volume":"16","author":"Javed","year":"2022","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.jtos.2025.03.004_bib396","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.micpath.2017.11.043","article-title":"An inhibitory action of chitosan nanoparticles against pathogenic bacteria and fungi and their potential applications as biocompatible antioxidants","volume":"114","author":"MubarakAli","year":"2018","journal-title":"Microb Pathog"},{"issue":"23","key":"10.1016\/j.jtos.2025.03.004_bib397","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237136","article-title":"Antimicrobial properties of chitosan and chitosan derivatives in the treatment of enteric infections","volume":"26","author":"Yan","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib398","first-page":"69","article-title":"Challenging case of treating fungal keratitis","volume":"66","author":"Ler","year":"2022","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib399","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2018.07.015","article-title":"Toxicological status of nanoparticles: what we know and what we don't know","volume":"295","author":"Missaoui","year":"2018","journal-title":"Chem Biol Interact"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092830","article-title":"Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application","volume":"19","author":"Tsai","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.jtos.2025.03.004_bib401","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201802289","article-title":"Safety assessment of nanomaterials to eyes: an important but neglected issue","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib402","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12951-022-01658-5","article-title":"Immune modulating nanoparticles for the treatment of ocular diseases","volume":"20","author":"Fang","year":"2022","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib403","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1167\/iovs.05-0495","article-title":"Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance","volume":"47","author":"de Salamanca","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2025.03.004_bib404","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08820538.2015.1114865","article-title":"Drug delivery nanoparticles: toxicity comparison in retinal pigment epithelium and retinal vascular endothelial cells","volume":"31","author":"Lin","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib405","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1208\/s12249-018-1256-0","article-title":"Stability, cytotoxicity, and retinal pigment epithelial cell binding of hyaluronic acid-coated PLGA nanoparticles encapsulating lutein","volume":"20","author":"Chittasupho","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib406","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00006982-199401000-00015","article-title":"Retinal toxicity of the antimetabolite 5-fluorouridine 5'-monophosphate administered intravitreally using multivesicular liposomes","volume":"14","author":"Gariano","year":"1994","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib407","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40942-019-0186-7","article-title":"In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus","volume":"5","author":"Abud","year":"2019","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib408","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jop.2020.0108","article-title":"Toxicity evaluation of a novel rapamycin liposomal formulation after subconjunctival and intravitreal injection","volume":"37","author":"Salas-Ambrosio","year":"2021","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2025.03.004_bib409","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfb.2013.06.047","article-title":"Ocular biocompatibility and tolerance study of biodegradable polymeric micelles in the rabbit eye","volume":"112","author":"Xu","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib410","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1177\/09603271211017314","article-title":"Ocular toxicity assessment of nanoemulsion in-situ gel formulation of fluconazole","volume":"40","author":"Samimi","year":"2021","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib411","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/tx100376n","article-title":"Studies of intracorneal distribution and cytotoxicity of quantum dots: risk assessment of eye exposure","volume":"24","author":"Kuo","year":"2011","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib412","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/nnm-2020-0471","article-title":"Intravitreal quantum dots for retinitis pigmentosa: a first-in-human safety study","volume":"16","author":"Jackson","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jtos.2025.03.004_bib413","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123506","article-title":"Cytotoxic and genotoxic properties of silver nanoparticles synthesized by ethanolic extract of Salacia chinensis","volume":"233","author":"Nagesh","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib414","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5487\/TR.2019.35.3.287","article-title":"In vitro cytotoxicity of zinc oxide nanoparticles in cultured statens seruminstitut rabbit cornea cells","volume":"35","author":"Lee","year":"2019","journal-title":"Toxicol Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib415","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ecoenv.2018.07.079","article-title":"Silver nanoparticles affect lens rather than retina development in zebrafish embryos","volume":"163","author":"Zhang","year":"2018","journal-title":"Ecotoxicol Environ Saf"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib416","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/nn800596w","article-title":"Cytotoxicity and genotoxicity of silver nanoparticles in human cells","volume":"3","author":"AshaRani","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.jtos.2025.03.004_bib417","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.2147\/IJN.S244785","article-title":"Silver nanoparticle-induced apoptosis in ARPE-19 cells is inhibited by Toxoplasma gondii pre-infection through suppression of NOX4-dependent ROS generation","author":"Quan","year":"2020","journal-title":"Int J Nanomed"},{"issue":"25","key":"10.1016\/j.jtos.2025.03.004_bib418","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.1039\/D0NR03208E","article-title":"Toxicity and mechanism of mesoporous silica nanoparticles in eyes","volume":"12","author":"Chen","year":"2020","journal-title":"Nanoscale"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib419","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105359","article-title":"Silver and gold nanoparticles exposure to in vitro cultured retina\u2013studies on nanoparticle internalization, apoptosis, oxidative stress, glial-and microglial activity","volume":"9","author":"S\u00f6derstjerna","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib420","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/toxsci\/kft081","article-title":"Gold nanoparticles disrupt zebrafish eye development and pigmentation","volume":"133","author":"Kim","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib421","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tiv.2016.08.013","article-title":"Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line","volume":"37","author":"Karako\u00e7ak","year":"2016","journal-title":"Toxicol Vitro"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib422","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.nano.2017.03.016","article-title":"Intraocular application of gold nanodisks optically tuned for optical coherence tomography: inhibitory effect on retinal neovascularization without unbearable toxicity","volume":"13","author":"Song","year":"2017","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib423","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IAE.0b013e3180dc9360","article-title":"Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model","volume":"28","author":"Bakri","year":"2008","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib424","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00253-023-12364-z","article-title":"Synthesis, biomedical applications, and toxicity of CuO nanoparticles","volume":"107","author":"Naz","year":"2023","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jtos.2025.03.004_bib425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biotno.2024.06.001","article-title":"The potential of copper oxide nanoparticles in nanomedicine: a comprehensive review","volume":"5","author":"Devaraji","year":"2024","journal-title":"Biotechnology Notes"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib426","first-page":"397","article-title":"Copper and copper nanoparticles toxicity and their impact on basic functions in the body","volume":"120","author":"Pohanka","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jtos.2025.03.004_bib427","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.placenta.2022.03.008","article-title":"Maternal, placental, and fetal distribution of titanium after repeated titanium dioxide nanoparticle inhalation through pregnancy","volume":"121","author":"D'Errico","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.jtos.2025.03.004_bib428","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jhazmat.2017.11.039","article-title":"Transcriptional responses and mechanisms of copper nanoparticle toxicology on zebrafish embryos","volume":"344","author":"Zhang","year":"2018","journal-title":"J Hazard Mater"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib429","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12964-020-00548-3","article-title":"Copper induce zebrafish retinal developmental defects via triggering stresses and apoptosis","volume":"18","author":"Zhao","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jtos.2025.03.004_bib430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1049\/nbt2.12085","article-title":"Diverse biotechnological applications of multifunctional titanium dioxide nanoparticles: an up-to-date review","volume":"16","author":"Javed","year":"2022","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.jtos.2025.03.004_bib431","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910519","article-title":"Review of antimicrobial properties of titanium dioxide nanoparticles","author":"Serov","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib432","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.18632\/aging.202412","article-title":"Toxic effect of titanium dioxide nanoparticles on corneas in vitro and in vivo","volume":"13","author":"Yang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib433","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12989-020-00395-7","article-title":"Titanium dioxide nanoparticles impair the inner blood-retinal barrier and retinal electrophysiology through rapid ADAM17 activation and claudin-5 degradation","volume":"18","author":"Chan","year":"2021","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.jtos.2025.03.004_bib434","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.2147\/IJN.S305676","article-title":"Size-dependent cytotoxicity and reactive oxygen species of cerium oxide nanoparticles in human retinal pigment epithelia cells","author":"Ma","year":"2021","journal-title":"Int J Nanomed"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib435","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/molecules25030441","article-title":"Treatment of human lens epithelium with high levels of nanoceria leads to reactive oxygen species mediated apoptosis","volume":"25","author":"Hanafy","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib436","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/21\/3\/035102","article-title":"Nanoceria have no genotoxic effect on human lens epithelial cells","volume":"21","author":"Pierscionek","year":"2010","journal-title":"Nanotechnology"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib437","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.nano.2011.06.016","article-title":"The effect of high concentration and exposure duration of nanoceria on human lens epithelial cells","volume":"8","author":"Pierscionek","year":"2012","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib438","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1124411","article-title":"The application of mesoporous silica nanoparticles as a drug delivery vehicle in oral disease treatment","volume":"13","author":"Fang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib439","doi-asserted-by":"crossref","DOI":"10.1038\/srep37762","article-title":"The effect of silica nanoparticles on human corneal epithelial cells","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib440","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/IJG.0000000000001709","article-title":"Effects of nonporous silica nanoparticles on human trabecular meshwork cells","volume":"30","author":"Kim","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jtos.2025.03.004_bib441","doi-asserted-by":"crossref","DOI":"10.3390\/nano11051240","article-title":"Graphene\/reduced graphene oxide-carbon nanotubes composite electrodes: from capacitive to battery-type behaviour","author":"Okhay","year":"2021","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib442","doi-asserted-by":"crossref","DOI":"10.3390\/nano13061059","article-title":"Single-walled vs. Multi-walled carbon nanotubes: influence of physico-chemical properties on toxicogenomics responses in mouse lungs","volume":"13","author":"Solorio-Rodriguez","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtos.2025.03.004_bib521","doi-asserted-by":"crossref","first-page":"100469","DOI":"10.1016\/j.cartre.2025.100469","article-title":"Polarization Raman Spectroscopy of aligned DNA-wrapped single-wall carbon nanotubes","author":"Banihashemian","year":"2025","journal-title":"Carbon Trends"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib443","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.toxlet.2009.09.007","article-title":"Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods","volume":"191","author":"Kishore","year":"2009","journal-title":"Toxicol Lett"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib444","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2131\/jts.34.555","article-title":"Safety evaluation of highly purified fullerenes (HPFs): based on screening of eye and skin damage","volume":"34","author":"Aoshima","year":"2009","journal-title":"J Toxicol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib445","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/15569527.2012.727937","article-title":"Dermal and ocular irritation and skin sensitization studies of fullerene C60 nanoparticles","volume":"32","author":"Ema","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib446","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/17435390.2016.1210692","article-title":"Evaluation of the toxicity of graphene oxide exposure to the eye","volume":"10","author":"Wu","year":"2016","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.jtos.2025.03.004_bib447","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exer.2018.05.024","article-title":"Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes","volume":"174","author":"An","year":"2018","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib448","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11869-022-01272-2","article-title":"Atmospheric micro (nano) plastics: future growing concerns for human health","volume":"16","author":"Bhat","year":"2023","journal-title":"Air Qual Atmos Health"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib449","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s11671-018-2457-x","article-title":"Dependence of nanoparticle toxicity on their physical and chemical properties","volume":"13","author":"Sukhanova","year":"2018","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.jtos.2025.03.004_bib450","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152952","article-title":"Nanosafety vs. nanotoxicology: adequate animal models for testing in vivo toxicity of nanoparticles","volume":"462","author":"Chrishtop","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.jtos.2025.03.004_bib451","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"4","author":"Singh","year":"2019","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.jtos.2025.03.004_bib452","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.reprotox.2015.05.015","article-title":"A perspective on the developmental toxicity of inhaled nanoparticles","volume":"56","author":"Hougaard","year":"2015","journal-title":"Reprod Toxicol"},{"issue":"28","key":"10.1016\/j.jtos.2025.03.004_bib453","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401060","article-title":"Nanoparticles dysregulate the human placental secretome with consequences on angiogenesis and vascularization","volume":"11","author":"Dugershaw-Kurzer","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib454","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116160","article-title":"The posterity of Zebrafish in paradigm of in vivo molecular toxicological profiling","volume":"171","author":"Verma","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtos.2025.03.004_bib455","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.4c00625","article-title":"Special distribution of nanoplastics in the central nervous system of zebrafish during early development","volume":"18","author":"Hong","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib456","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12989-020-00359-x","article-title":"Recent insights on indirect mechanisms in developmental toxicity of nanomaterials","volume":"17","author":"Dugershaw","year":"2020","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.jtos.2025.03.004_bib457","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.placenta.2020.12.014","article-title":"Research on nanoparticles in human perfused placenta: state of the art and perspectives","volume":"104","author":"Aengenheister","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.jtos.2025.03.004_bib474","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109339","article-title":"Biomaterials for dry eye disease treatment: current overview and future perspectives","volume":"226","author":"Thacker","year":"2023","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib475","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/nano14080669","article-title":"Recent advances in nanotechnology for the treatment of dry eye disease","volume":"14","author":"Coco","year":"2024","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtos.2025.03.004_bib476","first-page":"54","article-title":"Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes","volume":"19","author":"Gross","year":"2013","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2025.03.004_bib477","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s13346-016-0299-6","article-title":"Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration","volume":"6","author":"Du","year":"2016","journal-title":"Drug delivery and translational research"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib478","article-title":"A novel liposome-based, aminoacid-and vitamin-containing tear substitute in patients with evaporative dry eye disease. A pilot prospective study","volume":"2","author":"Modugno","year":"2021","journal-title":"J Comm Med and Pub Health Rep"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib479","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jcrs.2015.02.002","article-title":"Endothelial keratoplasty combined with cataract surgery or alone using polyethylene glycol hydrogel sealant for closure of corneal incisions","volume":"41","author":"Spierer","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jtos.2025.03.004_bib480","series-title":"ReSure\u00ae hydrogel sealant, and conventional suturing with 8-0 VICRYL\u00ae suture","article-title":"Comparison of conjunctival pedicle flap to corneal adhesion achieved by Tisseel\u00ae fibrin glue, ethyl cyanoacrylate adhesive","author":"VerHulst","year":"2023"},{"key":"10.1016\/j.jtos.2025.03.004_bib481","series-title":"Dexamethasone 0.4 mg sustained-release intracanalicular insert in the management of ocular inflammation and pain following ophthalmic surgery: design, development and place in therapy","first-page":"89","author":"Brooks","year":"2020"},{"key":"10.1016\/j.jtos.2025.03.004_bib482","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2147\/OPTH.S440840","article-title":"DEXTENZA versus topical steroid or antihistamine therapy for treatment of allergic conjunctivitis","author":"Reich","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib483","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2019.06.008","article-title":"Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections","volume":"142","author":"Agarwal","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib484","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"Bioimpacts: BI"},{"key":"10.1016\/j.jtos.2025.03.004_bib485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa\u00ae) for dry eye disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib486","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.2147\/OPTH.S279051","article-title":"A review of the mechanism of action of cyclosporine A: the role of cyclosporine A in dry eye disease and recent formulation developments","author":"Periman","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib487","series-title":"Tear lipid layer thickness and symptoms in patients with dry eye disease following the use of emollient versus non-emollient artificial tears","author":"Weisenberger","year":"2020"},{"key":"10.1016\/j.jtos.2025.03.004_bib488","series-title":"Safe and effective management of dry eye symptoms with hydroxypropyl guar and hyaluronic acid dual-polymer lubricating eye drops: a review of preclinical and clinical studies","first-page":"3883","author":"Srinivasan","year":"2023"},{"key":"10.1016\/j.jtos.2025.03.004_bib489","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114582","article-title":"Novel drug delivery systems for the management of dry eye","volume":"191","author":"Nagai","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib490","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.drudis.2016.04.002","article-title":"Modern approaches to the ocular delivery of cyclosporine A","volume":"21","author":"Agarwal","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtos.2025.03.004_bib491","series-title":"Oil-in-water nanoemulsions for glaucoma treatment: an insight into the latest trends","author":"Kishore","year":"2024"},{"key":"10.1016\/j.jtos.2025.03.004_bib492","first-page":"534","article-title":"Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment","volume":"361","author":"Guo","year":"2023","journal-title":"J Ophthalmol Clin Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib493","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2016.10.016","article-title":"Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye","volume":"153","author":"Daull","year":"2016","journal-title":"Exp Eye Res"},{"issue":"24","key":"10.1016\/j.jtos.2025.03.004_bib494","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1039\/D1BM01453F","article-title":"A hybrid ocular delivery system of cyclosporine-A comprising nanomicelle-laden polymeric inserts with improved efficacy and tolerability","volume":"9","author":"Terreni","year":"2021","journal-title":"Biomater Sci"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib495","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jop.2023.0166","article-title":"Pharmaceutical emulsions: a viable approach for ocular drug delivery","volume":"40","author":"Bisen","year":"2024","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.jtos.2025.03.004_bib496","series-title":"Quality by design (q\u044ad) approach for the development of topical ocular formulations","author":"Katta","year":"2018"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib497","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3390\/pharmaceutics14102221","article-title":"Besifloxacin nanocrystal: towards an innovative ophthalmic preparation","volume":"14","author":"Jesus","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib498","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102221","article-title":"Besifloxacin nanocrystal: towards an innovative ophthalmic preparation","volume":"14","author":"Jesus","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib499","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119552","article-title":"Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: in vitro, ex vivo and in vivo evaluation","volume":"585","author":"Polat","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib500","series-title":"Development and evaluation of a novel microemulsion of dexamethasone and tobramycin for topical ocular administration","author":"Bachu","year":"2017"},{"key":"10.1016\/j.jtos.2025.03.004_bib501","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2025.03.004_bib502","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124226","article-title":"Nanosuspensions in ophthalmology: overcoming challenges and enhancing drug delivery for eye diseases","volume":"658","author":"Fathi-Karkan","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2025.03.004_bib503","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212368","article-title":"Nanotechnology for topical drug delivery to the anterior segment of the eye","author":"Vaneev","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2025.03.004_bib504","doi-asserted-by":"crossref","unstructured":"S. Pardeshi, D. Pillai, P. Giram, C. Pardeshi, A. Gholap, J. Naik, Nanocarrier drug delivery systems chapter 15 nanocarriers for ocular drug delivery, in: P.L. Pingale, S. Baboota, J. Ali (Eds.), Therapeutic and diagnostic medicine, De Gruyter2024, pp. 469-500... .","DOI":"10.1515\/9783111320847-015"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib505","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/jop.2017.0052","article-title":"Relevance of lipid-based products in the management of dry eye disease","volume":"33","author":"Garrigue","year":"2017","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib506","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1888-4296(10)70021-2","article-title":"Visual and optical performance of silicone hydrogel contact lenses for moderate myopia","volume":"3","author":"Keir","year":"2010","journal-title":"J Optometry"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib507","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.03.004","article-title":"Objective evaluation of static and dynamic behavior of different toric silicone-hydrogel contact lenses","volume":"44","author":"S\u00e1nchez-Garc\u00eda","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib508","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e3181e3f05b","article-title":"Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry","volume":"29","author":"Luchs","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2025.03.004_bib509","first-page":"214","article-title":"Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life","volume":"107","author":"McDonald","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib510","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/aos.13744","article-title":"Fluocinolone acetonide intravitreal implant (Retisert(\u00ae)) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis","volume":"96","author":"Leinonen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib511","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40123-018-0130-1","article-title":"In vivo pharmacokinetics of bromfenac ophthalmic solution 0.075%, bromfenac ophthalmic solution 0.07%, and nepafenac\/amfenac ophthalmic suspension 0.3% in rabbits","volume":"7","author":"Sheppard","year":"2018","journal-title":"Ophthalmol Therap"},{"issue":"null","key":"10.1016\/j.jtos.2025.03.004_bib512","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2147\/OPTH.S208700","article-title":"Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies","volume":"13","author":"Schechter","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2025.03.004_bib458","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4155\/cli.14.135","article-title":"Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence","volume":"5","author":"Ames","year":"2015","journal-title":"Clin Invest"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib459","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jfo.2017.08.009","article-title":"[Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome]","volume":"41","author":"Boujnah","year":"2018","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"10.1016\/j.jtos.2025.03.004_bib460","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa\u00ae) for dry eye disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.jtos.2025.03.004_bib461","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.drudis.2019.05.006","article-title":"Therapeutic implications of nanomedicine for ocular drug delivery","volume":"24","author":"Meng","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtos.2025.03.004_bib462","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J Contr Release"},{"issue":"46","key":"10.1016\/j.jtos.2025.03.004_bib463","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.jtos.2025.03.004_bib464","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"597","author":"Henostroza","year":"2020","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.jtos.2025.03.004_bib465","article-title":"Nanotechnology-based formulations to amplify intraocular bioavailability","volume":"14","author":"Kagkelaris","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib466","volume":"5","author":"Eroglu","year":"2017","journal-title":"J Mark Access Health Policy"},{"issue":"14","key":"10.1016\/j.jtos.2025.03.004_bib467","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1080\/14656566.2019.1645834","article-title":"Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery","volume":"20","author":"Wentz","year":"2019","journal-title":"Expet Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.jtos.2025.03.004_bib468","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.03.004_bib469","article-title":"Use of rabbit eyes in pharmacokinetic studies of intraocular drugs","volume":"113","author":"Ahn","year":"2016","journal-title":"J Vis Exp"},{"issue":"12","key":"10.1016\/j.jtos.2025.03.004_bib470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11095-018-2519-x","article-title":"Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation","volume":"35","author":"Rodrigues","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.jtos.2025.03.004_bib471","series-title":"A randomized controlled trial comparing urea loaded nanoparticles to placebo: a new concept for cataract management, NCT03001466","year":"2016"},{"key":"10.1016\/j.jtos.2025.03.004_bib472","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/OPTH.S185800","article-title":"Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery","volume":"13","author":"Kim","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2025.03.004_bib473","series-title":"NCT02466399","article-title":"POLAT-001 compared to latanoprost ophthalmic solution in patients with ocular hypertension and open-angle glaucoma","year":"2020"},{"issue":"6","key":"10.1016\/j.jtos.2025.03.004_bib513","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1804","article-title":"Immunotoxicity of nanomaterials in health and disease: current challenges and emerging approaches for identifying immune modifiers in susceptible populations","volume":"14","author":"Hofer","year":"2022","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"10.1016\/j.jtos.2025.03.004_bib514","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch Med Sci"},{"issue":"5","key":"10.1016\/j.jtos.2025.03.004_bib515","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2023.04.011","article-title":"Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation","volume":"30","author":"Vandana","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib516","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13578-022-00775-w","article-title":"3D and organoid culture in research: physiology, hereditary genetic diseases and cancer","volume":"12","author":"Suarez-Martinez","year":"2022","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.jtos.2025.03.004_bib517","article-title":"Microphysiological systems: next generation systems for assessing toxicity and therapeutic effects of nanomaterials","volume":"4","author":"Ashammakhi","year":"2020","journal-title":"Small Methods"},{"issue":"9","key":"10.1016\/j.jtos.2025.03.004_bib518","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1535370214542068","article-title":"The relevance and potential roles of microphysiological systems in biology and medicine","volume":"239","author":"Wikswo","year":"2014","journal-title":"Exp Biol Med (Maywood, NJ, U S)"},{"key":"10.1016\/j.jtos.2025.03.004_bib519","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.728866","article-title":"An individual patient's \"body\" on chips-how organismoid theory can translate into your personal precision therapy approach","volume":"8","author":"Marx","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jtos.2025.03.004_bib520","first-page":"50","article-title":"Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration","volume":"19","author":"Kim","year":"2023","journal-title":"Bioact Mater"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:52:26Z","timestamp":1752576746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":521,"alternative-id":["S1542012425000485"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.03.004","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bringing ophthalmology into the scientific world: Novel nanoparticle-based strategies for ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}